Breast Cancer Clinical Trial
— COHECOfficial title:
Management of Perioperative Anxiety by the Fixed Rate Guided Breathing Technique (Cardiac Coherence) Coupled With a Hypnosis Session, as Part of the Improved Pre-habilitation After Surgery
Verified date | September 2023 |
Source | Institut du Cancer de Montpellier - Val d'Aurelle |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
the investigator proposes to use the cardiac coherence technique coupled with a hypnosis session to improve post-operative recovery.
Status | Completed |
Enrollment | 53 |
Est. completion date | January 14, 2022 |
Est. primary completion date | January 14, 2022 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Age = 18 years old 2. Surgery for breast or gynaecological cancer requiring scheduled hospitalization for up to 3 days 3. Signing of informed consent before any specific procedure in the study 4. Patient affiliated to a social security system Exclusion Criteria: 1. Patients undergoing outpatient surgery for their cancer will not be included 2. Natural bradycardia (50 beats per minute) 3. Patient taking ß-blockers, digoxin, flecaine, isoptin, cordarone, diltiazem 4. Cardiac arrhythmias 5. Severe heart failure with ventricular ejection fraction < 40% 6. Uncontrolled chronic pain 7. Patients whose medical or psychological conditions do not allow them to complete the study or sign the consent 8. Patient does not understand the French language 9. Deaf and/or dumb patient 10. Adult patient under guardianship or curatorship |
Country | Name | City | State |
---|---|---|---|
France | Institut régional du cancer de Montpellier | Montpellier | Hérault |
Lead Sponsor | Collaborator |
---|---|
Institut du Cancer de Montpellier - Val d'Aurelle |
France,
Agelink MW, Majewski TB, Andrich J, Mueck-Weymann M. Short-term effects of intravenous benzodiazepines on autonomic neurocardiac regulation in humans: a comparison between midazolam, diazepam, and lorazepam. Crit Care Med. 2002 May;30(5):997-1006. doi: 10.1097/00003246-200205000-00008. — View Citation
Lepouse C, Lautner CA, Liu L, Gomis P, Leon A. Emergence delirium in adults in the post-anaesthesia care unit. Br J Anaesth. 2006 Jun;96(6):747-53. doi: 10.1093/bja/ael094. Epub 2006 May 2. — View Citation
McCraty R, Atkinson M, Tiller WA, Rein G, Watkins AD. The effects of emotions on short-term power spectrum analysis of heart rate variability. Am J Cardiol. 1995 Nov 15;76(14):1089-93. doi: 10.1016/s0002-9149(99)80309-9. Erratum In: Am J Cardiol 1996 Feb 1;77(4):330. — View Citation
Munoz HR, Dagnino JA, Rufs JA, Bugedo GJ. Benzodiazepine premedication causes hypoxemia during spinal anesthesia in geriatric patients. Reg Anesth. 1992 May-Jun;17(3):139-42. — View Citation
Pekcan M, Celebioglu B, Demir B, Saricaoglu F, Hascelik G, Yukselen MA, Basgul E, Aypar U. The effect of premedication on preoperative anxiety. Middle East J Anaesthesiol. 2005 Jun;18(2):421-33. — View Citation
Van den Bosch JE, Moons KG, Bonsel GJ, Kalkman CJ. Does measurement of preoperative anxiety have added value for predicting postoperative nausea and vomiting? Anesth Analg. 2005 May;100(5):1525-1532. doi: 10.1213/01.ANE.0000149325.20542.D4. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Proportion of patients who have enrolled in the pre-habilitation program | A patient will be considered to have optimally adhered to the program if she performs at least 2/3 of the proposed cardiac coherence sessions (that represents 67% of the total number of sessions), that is, at least 14 sessions over the 7 days preceding the surgery. | 7 days | |
Secondary | The preoperative anxiety score by using the Amsterdam Preoperative Anxiety and Information Scale (APAIS) | The anxiety scale consists of six items, each of which could be scored from 1 to 5 with the end poles "not at all" (1) and "extremely" (5). The score of the anxiety scale is the sum of these four questions, with a scoring range from 6 to 30. | 7 days | |
Secondary | Patient's satisfaction with perioperative period by using "Evaluation of the Vecu of General Anesthesia" questionnaire (EVAN-G) | The validated EVAN-G questionnaire includes 26 questions whose results are grouped together to define 6 "dimensions": Attention Focus, Information, Privacy, Pain, Discomfort and Wait Times. From these scores, an overall satisfaction score is calculated (average of all scores). For each of the scores: the higher the score, the higher the satisfaction. For each dimension, scores were reduced on a scale from 0 to 100. The higher the score, the higher the perceived quality of the experience. The total score was the sum of the scores of the six dimensions reduced to 100. | 48 hours | |
Secondary | Measurement of the Postoperative Quality of Recovery (QoR) | The quality of postoperative functional recovery will be assessed by the QoR-15 questionnaire, which assesses five dimensions of recovery (physical comfort ; emotional state ; physical independence ; physiological support ; and pain). Each item was rated on a ten-point Likert scale: none of the time, some of the time, usually, most of the time, and all the time. The total score on the QoR-15 ranges from 0 (poorest quality of recovery) to 150 (best quality of recovery). | 10 days | |
Secondary | Measurement of anxiety level by using a visual analogue scale | It's a visual scale from 0 (no anxiety) to 100 (highest anxiety) | 7 days | |
Secondary | Measurement of wake-up quality by using a visual analogue scale | It's a visual scale from 0 (best wake-up) to 100 (worst wake-up) | 1 day | |
Secondary | Measurement of post-operative pain by using a visual analogue scale | It's a visual scale from 0 (no pain) to 100 (highest pain) | 1 day | |
Secondary | Measurement of post-operative fatigue by using a visual analogue scale | It's a visual scale from 0 (no fatigue) to 100 (highest fatigue) | 1 day | |
Secondary | Measurement of comfort and satisfaction with care by using a visual analogue scale | It's a visual scale from 0 (ideal care) to 100 worst care) | 1 day | |
Secondary | Number of patients taking anesthetic drugs at induction of anaesthesia | 1 day | ||
Secondary | Number of patients taking anesthetic drugs during the post-interventional monitoring | 1 day | ||
Secondary | Number of patients taking morphine in recovery room | 1 day | ||
Secondary | Number of patients taking setrons (nausea and vomiting medication) | 1 day | ||
Secondary | Rate of patients that consider continuing the program of cardiac coherence | 1 day | ||
Secondary | Rate of patients willing to recommend the technique | 1 day | ||
Secondary | Number of days of hospitalization | 1 month | ||
Secondary | Number of patients taking morphine in peroperative | 1 day | ||
Secondary | Measurement of pain at inclusion by using a visual analogue scale | It's a visual scale from 0 (no pain) to 100 (highest pain) | 1 day | |
Secondary | The recruitment rate (proportion of patients consenting to participate in the study among eligible patients at the screening) and reasons for refusal. | 1 day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |